STOCK TITAN

QuidelOrtho (QDEL) director receives 1,183 shares from restricted stock unit release

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

QuidelOrtho Corp director Kenneth J. Widder reported routine equity compensation activity involving restricted stock units. On June 6, 2026, he acquired 273 and 910 shares of common stock at $0.00 per share through grants/awards.

These shares came from the release and conversion of previously reported restricted stock units into common stock, with 273 and 910 units exercised at a $0.00 conversion price. Footnotes explain that the restricted stock unit release had been deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors and occurred according to his elected deferral schedule.

Positive

  • None.

Negative

  • None.
Insider WIDDER KENNETH J
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units (Converted) 910 $0.00 --
Exercise Restricted Stock Units (Premium) 273 $0.00 --
Grant/Award Common Stock 910 $0.00 --
Grant/Award Common Stock 273 $0.00 --
Holdings After Transaction: Restricted Stock Units (Converted) — 0 shares (Direct, null); Restricted Stock Units (Premium) — 0 shares (Direct, null); Common Stock — 44,800 shares (Direct, null)
Footnotes (1)
  1. Reflects release of restricted stock units that were previously reported on a Form 4. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Share grant 1 273 shares Common stock grant/award on June 6, 2026 at $0.00
Share grant 2 910 shares Common stock grant/award on June 6, 2026 at $0.00
RSUs exercised total 1,183 units Restricted stock units converted to common stock
Exercise price $0.00 per unit Conversion of restricted stock units into common stock
restricted stock units financial
"Reflects release of restricted stock units that were previously reported on a Form 4."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
restricted stock unit financial
"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
deferred compensation program financial
"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
non-employee directors financial
"QuidelOrtho's deferred compensation program applicable to participating non-employee directors"
Non-employee directors are board members who do not work for the company as salaried employees and usually do not hold day-to-day management roles. They act like outside referees or independent coaches, providing oversight, asking tough questions, and protecting shareholders’ interests; investors care because these directors help ensure management is accountable, reduce conflicts of interest, and influence decisions that affect company strategy and long-term value.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WIDDER KENNETH J

(Last)(First)(Middle)
9975 SUMMERS RIDGE ROAD

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/06/2026A910(1)A$044,800D
Common Stock06/06/2026A273(1)A$045,073D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (Converted)(2)06/06/2026M910 (3) (3)Common Stock910$00D
Restricted Stock Units (Premium)(2)06/06/2026M273 (3) (3)Common Stock273$00D
Explanation of Responses:
1. Reflects release of restricted stock units that were previously reported on a Form 4.
2. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
3. Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule.
Remarks:
/s/ Phillip S. Askim, attorney-in-fact for Kenneth J. Widder06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did QuidelOrtho (QDEL) director Kenneth Widder report in this Form 4?

Kenneth J. Widder reported the acquisition of common shares tied to restricted stock units. On June 6, 2026, previously granted units were released and converted into QuidelOrtho common stock as part of his non-employee director compensation.

How many QuidelOrtho (QDEL) shares were involved in Kenneth Widder’s Form 4?

The filing shows 273 and 910 shares of QuidelOrtho common stock acquired. These totals, 1,183 shares combined, arose from the release and conversion of restricted stock units into common stock under the company’s director compensation arrangements.

Were Kenneth Widder’s QuidelOrtho (QDEL) transactions open-market purchases or sales?

The transactions were not open-market trades. They reflect grants and the exercise or conversion of restricted stock units at a zero-dollar price, consistent with equity compensation rather than discretionary buying or selling in the market.

What are the restricted stock units referenced in QuidelOrtho (QDEL) director Widder’s filing?

Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. In this filing, units previously reported on an earlier Form 4 were released and converted into common shares according to the applicable plan terms.

How does QuidelOrtho’s deferred compensation program affect this Form 4 for QDEL?

The filing notes that restricted stock unit releases were deferred under QuidelOrtho’s deferred compensation program for participating non-employee directors. The actual conversion into common shares occurred according to Kenneth Widder’s previously elected deferral schedule.

Does this QuidelOrtho (QDEL) Form 4 indicate a change in Kenneth Widder’s trading views?

The Form 4 reflects routine compensation-related equity releases and conversions, not discretionary market trades. It records the scheduled delivery of shares from prior restricted stock unit awards under the company’s non-employee director compensation and deferral programs.